Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|29 Apr 2013||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|4 Jun 2013||Reviewed||Reviewer Report - Wan-Teck Lim|
|5 Jun 2013||Reviewed||Reviewer Report - Balazs Halmos|
|20 Aug 2013||Author responded||Author comments - Michael Maitland|
|Resubmission - Version 4|
|20 Aug 2013||Submitted||Manuscript version 4|
|12 Dec 2013||Editorially accepted|
|4 Jan 2014||Article published||10.1186/1471-2407-14-5|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.